SynBioBeta is where the people building with biology meet the people funding, buying, and partnering with them. If you're raising capital, scouting the next wave of AIxBIO companies, or looking for your next technology partner - the people you need are here for three days.
The startups on stage this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and proteins that replace sugar - alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Mars, Apple, Google, NVIDIA, Unilever, and P&G.
Watching where the partnerships form and which technologies the biggest players are actually evaluating is something you can't get from a report or a webinar. And our 1:1 Partnering App lets you book meetings before you arrive.
Eric Schmidt
Former CEO
"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."
Celestine Schnugg
Founder
Surge Biswas
Founder
Jacob Glanville
Founder & CEO
Bill Tai
Co-founder
Luis Cascao-Pereira
Head of Digital Biology
Ola Wlodek
CEO
Who’s Coming to SynBioBeta?
Funders writing checks and looking for their next company.
The Startups they'll be meeting with.
1 Day Pass
995
USD
Access to All Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
